Efficacy and Safety of Once-Weekly Tirzepatide in Participants With Obesity Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-J)
收藏DataCite Commons2026-03-13 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012839/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to learn more about tirzepatide in participants with obesity disease. The study will also measure how Tirzepatide affects body weight with a low-calorie diet and increased physical activity. The study will last around 72 Weeks.
提供机构：
Vivli
创建时间：
2026-03-13
